Concentra Group Holdings Parent (CON) Proxy Filing summary

Executive summary

• The 2025 Annual Meeting will be held virtually on May 1, 2025, with voting on director elections, executive compensation, advisory vote frequency, and auditor ratification.

• Only stockholders of record as of March 7, 2025, are eligible to vote, with 128,171,952 shares outstanding.

• The Board recommends voting for all proposals, including annual say-on-pay and auditor ratification.

Voting matters and shareholder proposals

• Proposals include electing two Class I directors, a non-binding advisory vote on executive compensation, a vote on the frequency of the advisory vote, and ratification of PricewaterhouseCoopers LLP as auditor.

• The Board recommends annual frequency for the say-on-pay vote.

• Shareholder proposals for the 2026 meeting must be received by November 18, 2025, to be included.

Board of directors and corporate governance

• The Board consists of five members, with a majority being independent as per NYSE standards.

• Transitioning from controlled company status, full compliance with NYSE independence requirements is expected by November 2025.

• Committees include Audit and Compliance, Human Capital and Compensation, Nominating, Governance and Sustainability, and Quality of Care and Patient Safety.

• Lead Director role established for independent oversight; Mr. Daniel Thomas serves in this capacity.

• Directors are expected to attend all meetings and adhere to corporate governance guidelines.